Cargando…

EPIDEMIOLOGICAL PROFILE AND EVOLUTION OF ANKLE MUSCULOSKELETAL TUMORS

OBJECTIVE: Characterizing ankle tumors, presenting the epidemiological profile of these lesions. METHODS: Retrospective observational case series study to evaluate the results of clinical and/or surgical treatments of patients with ankle tumors whose first visit occurred from 1990 to 2020. The depen...

Descripción completa

Detalles Bibliográficos
Autores principales: OLIVEIRA, NATHALIA SUNDIN PALMEIRA DE, GARCIA, JAIRO GRECO, KALLUF, JULIA ROCHA, OGATA, FIAMA KURODA, HARING, BARBARA MORA, PETRILLI, MARCELO DE TOLEDO, KORUKIAN, MARCOS, VIOLA, DAN CARAI MAIA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ATHA EDITORA 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757721/
https://www.ncbi.nlm.nih.gov/pubmed/36561478
http://dx.doi.org/10.1590/1413-785220223006e256757
_version_ 1784851883500765184
author OLIVEIRA, NATHALIA SUNDIN PALMEIRA DE
GARCIA, JAIRO GRECO
KALLUF, JULIA ROCHA
OGATA, FIAMA KURODA
HARING, BARBARA MORA
PETRILLI, MARCELO DE TOLEDO
KORUKIAN, MARCOS
VIOLA, DAN CARAI MAIA
author_facet OLIVEIRA, NATHALIA SUNDIN PALMEIRA DE
GARCIA, JAIRO GRECO
KALLUF, JULIA ROCHA
OGATA, FIAMA KURODA
HARING, BARBARA MORA
PETRILLI, MARCELO DE TOLEDO
KORUKIAN, MARCOS
VIOLA, DAN CARAI MAIA
author_sort OLIVEIRA, NATHALIA SUNDIN PALMEIRA DE
collection PubMed
description OBJECTIVE: Characterizing ankle tumors, presenting the epidemiological profile of these lesions. METHODS: Retrospective observational case series study to evaluate the results of clinical and/or surgical treatments of patients with ankle tumors whose first visit occurred from 1990 to 2020. The dependent variables were: benign bone tumor, malignant bone tumor, benign soft tissue tumor, malignant soft tissue tumor, and infection. The independent variables were: sex, age; presence of symptoms (pain/local volume increase/fracture), duration of symptoms until treatment, diagnosis, treatment, and recurrence. RESULTS: In total, 70 patients were included-58.5% were women, with a mean age at the time of diagnosis of 21.66 years. Among all cases, 76% were bone tumor, 14% were soft tissue tumor, and 10% were infection. The mean age at the time of diagnosis was 21.7 ± 2.29 years. The overall prevalence of pain was 77.1%. In total, 55.6% patients had a general local volume increase 13.4% had fractures. The mean time from symptoms to treatment was 17.4 ± 4.61 months and the mean diagnosis time was 10.13 ± 0.86 months. Of all cases, 73.44% underwent surgical treatment and 22.64% had recurrence. CONCLUSION: In this series, ankle tumors corresponded mainly to bone tumors. Benign tumors were the most prevalent type of tumor and the highest occurrence was among young people. Level of Evidence IV, Case Series.
format Online
Article
Text
id pubmed-9757721
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher ATHA EDITORA
record_format MEDLINE/PubMed
spelling pubmed-97577212022-12-21 EPIDEMIOLOGICAL PROFILE AND EVOLUTION OF ANKLE MUSCULOSKELETAL TUMORS OLIVEIRA, NATHALIA SUNDIN PALMEIRA DE GARCIA, JAIRO GRECO KALLUF, JULIA ROCHA OGATA, FIAMA KURODA HARING, BARBARA MORA PETRILLI, MARCELO DE TOLEDO KORUKIAN, MARCOS VIOLA, DAN CARAI MAIA Acta Ortop Bras Original Article OBJECTIVE: Characterizing ankle tumors, presenting the epidemiological profile of these lesions. METHODS: Retrospective observational case series study to evaluate the results of clinical and/or surgical treatments of patients with ankle tumors whose first visit occurred from 1990 to 2020. The dependent variables were: benign bone tumor, malignant bone tumor, benign soft tissue tumor, malignant soft tissue tumor, and infection. The independent variables were: sex, age; presence of symptoms (pain/local volume increase/fracture), duration of symptoms until treatment, diagnosis, treatment, and recurrence. RESULTS: In total, 70 patients were included-58.5% were women, with a mean age at the time of diagnosis of 21.66 years. Among all cases, 76% were bone tumor, 14% were soft tissue tumor, and 10% were infection. The mean age at the time of diagnosis was 21.7 ± 2.29 years. The overall prevalence of pain was 77.1%. In total, 55.6% patients had a general local volume increase 13.4% had fractures. The mean time from symptoms to treatment was 17.4 ± 4.61 months and the mean diagnosis time was 10.13 ± 0.86 months. Of all cases, 73.44% underwent surgical treatment and 22.64% had recurrence. CONCLUSION: In this series, ankle tumors corresponded mainly to bone tumors. Benign tumors were the most prevalent type of tumor and the highest occurrence was among young people. Level of Evidence IV, Case Series. ATHA EDITORA 2022-12-16 /pmc/articles/PMC9757721/ /pubmed/36561478 http://dx.doi.org/10.1590/1413-785220223006e256757 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Original Article
OLIVEIRA, NATHALIA SUNDIN PALMEIRA DE
GARCIA, JAIRO GRECO
KALLUF, JULIA ROCHA
OGATA, FIAMA KURODA
HARING, BARBARA MORA
PETRILLI, MARCELO DE TOLEDO
KORUKIAN, MARCOS
VIOLA, DAN CARAI MAIA
EPIDEMIOLOGICAL PROFILE AND EVOLUTION OF ANKLE MUSCULOSKELETAL TUMORS
title EPIDEMIOLOGICAL PROFILE AND EVOLUTION OF ANKLE MUSCULOSKELETAL TUMORS
title_full EPIDEMIOLOGICAL PROFILE AND EVOLUTION OF ANKLE MUSCULOSKELETAL TUMORS
title_fullStr EPIDEMIOLOGICAL PROFILE AND EVOLUTION OF ANKLE MUSCULOSKELETAL TUMORS
title_full_unstemmed EPIDEMIOLOGICAL PROFILE AND EVOLUTION OF ANKLE MUSCULOSKELETAL TUMORS
title_short EPIDEMIOLOGICAL PROFILE AND EVOLUTION OF ANKLE MUSCULOSKELETAL TUMORS
title_sort epidemiological profile and evolution of ankle musculoskeletal tumors
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757721/
https://www.ncbi.nlm.nih.gov/pubmed/36561478
http://dx.doi.org/10.1590/1413-785220223006e256757
work_keys_str_mv AT oliveiranathaliasundinpalmeirade epidemiologicalprofileandevolutionofanklemusculoskeletaltumors
AT garciajairogreco epidemiologicalprofileandevolutionofanklemusculoskeletaltumors
AT kallufjuliarocha epidemiologicalprofileandevolutionofanklemusculoskeletaltumors
AT ogatafiamakuroda epidemiologicalprofileandevolutionofanklemusculoskeletaltumors
AT haringbarbaramora epidemiologicalprofileandevolutionofanklemusculoskeletaltumors
AT petrillimarcelodetoledo epidemiologicalprofileandevolutionofanklemusculoskeletaltumors
AT korukianmarcos epidemiologicalprofileandevolutionofanklemusculoskeletaltumors
AT violadancaraimaia epidemiologicalprofileandevolutionofanklemusculoskeletaltumors